GREEN TECHNOLOGY,CREATE BETTER LIFE GREEN TECHNOLOGY,CREATE BETTER LIFE

GREEN TECHNOLOGY,CREATE BETTER LIFE

查看详情+
GREEN TECHNOLOGY,CREATE BETTER LIFE GREEN TECHNOLOGY,CREATE BETTER LIFE

GREEN TECHNOLOGY,CREATE BETTER LIFE

查看详情+
GREEN TECHNOLOGY,CREATE BETTER LIFE GREEN TECHNOLOGY,CREATE BETTER LIFE

GREEN TECHNOLOGY,CREATE BETTER LIFE

查看详情+

ABOUT US

SyncoZymes (Shanghai) Co., Ltd. is founded in 2007 and located in southern district of Shanghai Pudong Zhangjiang High-tech Park, the International Medical Park. SyncoZymes (Shanghai) is a subsidiary company of SyncoZymes (Zhejiang) Co., Ltd. SyncoZymes is committed to the research and development of cutting-edge technologies and products in the field of green pharmaceuticals, leading the development of the chemical pharmaceutical industry with green biotechnology, and providing high-quality products and services to the customers of pharmaceutical and healthy industry.

  • 001

    40

    Enzyme Systems +

    Bio-catalysis Expert

  • 001

    10000

    Enzymes +

    Large Enzyme Library open to customer

  • 001

    1200

    Tons +

    Annual Capacity of Enzymes and Coenzymes

  • 001

    100

    Pieces +

    Patent Application

  • Enzymes
    SyncoZymes has a large enzyme library with 40 series and more than 10,000 enzymes, which can be applied to various types of chemical transformation reactions. Each type of enzyme can be made into enzyme plate for high-throughput screening. The company provides enzyme plate screening services, as well as the development of enzymes for biotransformation, the design and optimization of biotransformation processes, and the transfer of strains.
    More +
  • Co-enzymes
    SyncoZymes supplies co-enzyme of NAD series products, including NMN, NAD, NADP, NADH, NADPH, with an annual output of 100 tons, is one of the main suppliers of NAD-family coenzyme products in the world.
    More +
  • Functional Food Raw Materials
    SyncoZymes uses biocatalysis technology to develop green natural functional food raw materials, and produces them in strict accordance with the pharmaceutical standard system. It continuously explores the effects and mechanisms of natural ingredients on human health, realizes the green manufacturing of natural ingredients and provides scientific, safe and effective health for human beings.
    More +
  • Pharmaceutical Intermediates
    SyncoZymes has a strong biotechnology platform, chemical technology platform and GMP production system, focusing on the development and application of biological enzymes, focusing on the research and development and production of pharmaceutical intermediates.
    More +
  • CRO/CDMO Services
    SyncoZymes has a strong biotechnology platform, chemical technology platform, testing and quality research platform and GMP production system, focusing on the development and application research of biological enzymes, focusing on the research and development and application of green biotechnology pharmaceutical intermediates, APIs, functional food raw materials. At the same time, She provides high-end CRO, CDMO services, testing and quality research services.
    More +
  • Testing and Quality Research Services
    SyncoZymes undertakes the management and operation of the R&D public service platform in Shanghai International Medical Park, and can provide testing and quality research services for small molecule drug research and development. SyncoZymes equipped with NMR, LCMS, GCMS, HPLC, GC, protein purification, crystal form detection, preparative chromatography and other instrument.
    More +
Products and Services
SyncoZymes (Shanghai) Co., Ltd., has a strong biotechnology platform, chemical technology platform, testing and quality research platform and GMP production platform. SyncoZymes focuses on the developing and applicating of biological enzymes and biocatalysis technologies, as well as synthetic biology technologies. SyncoZymes' main business is the research, development, production and sales of enzymes, co-enzymes, pharmaceutical intermediates, and functional food raw materials, and provides high-end CRO, CDMO services, testing and quality research services for customers.
Learn More

R & D system

25

2022-07

After strict review by the professional committee of the US FDA (US Food and Drug Administration) authoritative organization, on May 17, 2022, SyncoZymes (Shanghai) Co., Ltd. officially received the FDA's confirmation letter (AKL): NMN raw material successfully passed NDI (New Dietary Ingredient) approval.

25

2022-11

Radiation-induced intestinal fibrosis is a common complication of long-term survivors after abdominal and pelvic radiotherapy. At present, there is no clinically available method to treat radiation-induced intestinal fibrosis. Studies have shown that nicotinamide mononucleotide (NMN) has the potential to regulate intestinal flora. Intestinal flora is a normal microorganism in human intestines, which can synthesize a variety of nutrients necessary for human growth and development. Once the intestinal flora is out of balance, it will cause a variety of diseases.

11

2022-11

Spermine is a substance existing in the human body. With the increase of age, the level of spermidine in the body decreases. Supplementing spermidine is helpful to self-cleaning in the human body. Old and redundant cellular components and harmful invaders such as viruses will be decomposed and recycled. Finally, it can improve, renew and purify cells from the root of cells, and then avoid various chronic diseases and metabolic diseases caused by cell damage.

04

2022-11

Triglyceride (TG) is a kind of fat with a large content in human body. All organs and tissues of human body can use triglyceride to provide energy, and the liver can synthesize triglyceride and store it in the liver. If the triglyceride is increased, it means that the liver accumulates too much fat, which is fatty liver. Triglyceride is a kind of hyperlipidemia, and its main harm to human body is to cause atherosclerosis, blood vessel blockage and thrombosis. In addition, studies have shown that high triglycerides can also cause hypertension, gallstones, pancreatitis, Alzheimer's disease and so on.

21

2022-10

Compared with NAM, oral NMN and NR can increase NAD+ level more efficiently and have better safety and tolerance, which is a potential treatment strategy for dermatologists to reduce the risk of keratinocyte cancer. However, it still needs a lot of clinical research data to verify its practical application in clinical treatment.
×

Search

Search
×